[Vasopressor amines in the presence of halogenated agents].
D000605:Amino Alcohols / Q000009:adverse effects; D000769:Anesthesia, Inhalation; D000818:Animals; D001145:Arrhythmias, Cardiac / Q000139:chemically induced*; D004285:Dogs; D005260:Female; D006221:Halothane; D008297:Male; D008680:Metaraminol / Q000009:adverse effects; D008733:Methoxyflurane; D010627:Phenethylamines / Q000009:adverse effects; D010636:Phenols / Q000009:adverse effects; D011437:Propylamines / Q000009:adverse effects; D014662:Vasoconstrictor Agents / Q000009:adverse effects*
D000605:Amino Alcohols; D010627:Phenethylamines; D010636:Phenols; D011437:Propylamines; D014662:Vasoconstrictor Agents; D008733:Methoxyflurane; D008680:Metaraminol; D006221:Halothane
Aminas vasopressoras em presença de halogenados.